Richard A. Heyman - Net Worth and Insider Trading

Richard A. Heyman Net Worth

The estimated net worth of Richard A. Heyman is at least $7 Million dollars as of 2024-11-05. Richard A. Heyman is the Director of Enliven Therapeutics Inc and owns about 188,245 shares of Enliven Therapeutics Inc (ELVN) stock worth over $5 Million. Richard A. Heyman is also the Director of ORIC Pharmaceuticals Inc and owns about 228,772 shares of ORIC Pharmaceuticals Inc (ORIC) stock worth over $2 Million. Details can be seen in Richard A. Heyman's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Richard A. Heyman has not made any transactions after 2024-10-18 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Richard A. Heyman

To

Richard A. Heyman Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Richard A. Heyman owns 11 companies in total, including PMV Pharmaceuticals Inc (PMVP) , Metacrine Inc (MTCR) , and BCTG Acquisition Corp (BCTG) among others .

Click here to see the complete history of Richard A. Heyman’s form 4 insider trades.

Insider Ownership Summary of Richard A. Heyman

Ticker Comapny Transaction Date Type of Owner
PMVP PMV Pharmaceuticals Inc 2020-09-24 director
MTCR Metacrine Inc 2020-09-15 director
BCTG BCTG Acquisition Corp 2020-09-02 director
LIMIT LIMIT 2018-09-27 director
LIMIT LIMIT 2021-09-15 director
LIMIT LIMIT 2013-08-21 director
LIMIT LIMIT 2020-12-22 director
LIMIT LIMIT 2020-09-02 director
LIMIT LIMIT 2020-12-22 director
LIMIT LIMIT 2024-10-18 director
LIMIT LIMIT 2023-09-14 director

Richard A. Heyman Latest Holdings Summary

Richard A. Heyman currently owns a total of 2 stocks. Among these stocks, Richard A. Heyman owns 188,245 shares of Enliven Therapeutics Inc (ELVN) as of October 18, 2024, with a value of $5 Million and a weighting of 70.42%. Richard A. Heyman also owns 228,772 shares of ORIC Pharmaceuticals Inc (ORIC) as of September 15, 2021, with a value of $2 Million and a weighting of 29.58%.

Latest Holdings of Richard A. Heyman

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ELVN Enliven Therapeutics Inc 2024-10-18 188,245 28.01 5,272,742
ORIC ORIC Pharmaceuticals Inc 2021-09-15 228,772 9.68 2,214,513

Holding Weightings of Richard A. Heyman


Richard A. Heyman Form 4 Trading Tracker

According to the SEC Form 4 filings, Richard A. Heyman has made a total of 16 transactions in Enliven Therapeutics Inc (ELVN) over the past 5 years, including 0 buys and 16 sells. The most-recent trade in Enliven Therapeutics Inc is the sale of 1,570 shares on October 18, 2024, which brought Richard A. Heyman around $47,100.

According to the SEC Form 4 filings, Richard A. Heyman has made a total of 7 transactions in ORIC Pharmaceuticals Inc (ORIC) over the past 5 years, including 0 buys and 7 sells. The most-recent trade in ORIC Pharmaceuticals Inc is the sale of 1,388 shares on September 15, 2021, which brought Richard A. Heyman around $34,756.

Insider Trading History of Richard A. Heyman

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Richard A. Heyman Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Richard A. Heyman Ownership Network

Ownership Network List of Richard A. Heyman

No Data

Ownership Network Relation of Richard A. Heyman

Insider Network Chart

Richard A. Heyman Owned Company Details

What does PMV Pharmaceuticals Inc do?

Who are the key executives at PMV Pharmaceuticals Inc?

Richard A. Heyman is the director of PMV Pharmaceuticals Inc. Other key executives at PMV Pharmaceuticals Inc include SVP & Regulatory Affairs and QA Deepika Jalota , 10 percent owner Orbimed Advisors Llc , and Chief Medical Officer Leila Alland .

PMV Pharmaceuticals Inc (PMVP) Insider Trades Summary

Over the past 18 months, Richard A. Heyman made no insider transaction in PMV Pharmaceuticals Inc (PMVP). Other recent insider transactions involving PMV Pharmaceuticals Inc (PMVP) include a net sale of 11,322 shares made by Deepika Jalota , a net sale of 87,786 shares made by Orbimed Advisors Llc , and a net sale of 6,291 shares made by Leila Alland .

In summary, during the past 3 months, insiders sold 10,109 shares of PMV Pharmaceuticals Inc (PMVP) in total and bought 0 shares, with a net sale of 10,109 shares. During the past 18 months, 108,290 shares of PMV Pharmaceuticals Inc (PMVP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 108,290 shares.

PMV Pharmaceuticals Inc (PMVP)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

PMV Pharmaceuticals Inc Insider Transactions

No Available Data

Richard A. Heyman Mailing Address

Above is the net worth, insider trading, and ownership report for Richard A. Heyman. You might contact Richard A. Heyman via mailing address: 5871 Oberlin Drive, Suite 150, San Diego Ca 92121.